TRANSENTERIX INC's ticker is TRXC and the CUSIP is 89366M201. A total of 87 filers reported holding TRANSENTERIX INC in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,262,000 | +77.0% | 530,162 | +67.9% | 0.00% | 0.0% |
Q4 2018 | $713,000 | -80.6% | 315,688 | -50.3% | 0.00% | 0.0% |
Q3 2018 | $3,684,000 | +146.9% | 635,092 | +85.6% | 0.00% | 0.0% |
Q2 2018 | $1,492,000 | +545.9% | 342,203 | +79.1% | 0.00% | – |
Q1 2017 | $231,000 | -10.5% | 191,034 | -3.6% | 0.00% | – |
Q4 2016 | $258,000 | -20.6% | 198,137 | +3.1% | 0.00% | – |
Q3 2016 | $325,000 | +46.4% | 192,224 | +5.8% | 0.00% | – |
Q2 2016 | $222,000 | -59.7% | 181,759 | +40.1% | 0.00% | – |
Q1 2016 | $551,000 | +55.2% | 129,735 | -9.3% | 0.00% | – |
Q4 2015 | $355,000 | +9.9% | 143,047 | 0.0% | 0.00% | – |
Q3 2015 | $323,000 | -55.7% | 143,047 | -41.2% | 0.00% | -100.0% |
Q2 2015 | $729,000 | +56.4% | 243,072 | +52.7% | 0.00% | – |
Q1 2015 | $466,000 | +31.3% | 159,143 | +30.5% | 0.00% | – |
Q4 2014 | $355,000 | -31.9% | 121,993 | +2.0% | 0.00% | – |
Q3 2014 | $521,000 | -27.5% | 119,559 | -16.1% | 0.00% | -100.0% |
Q2 2014 | $719,000 | – | 142,570 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 7,546,692 | $12,829,000 | 9.62% |
StepStone Group LP | 3,032,625 | $5,155,000 | 3.79% |
Aisling Capital LLC | 9,889,352 | $16,812,000 | 3.00% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 519,548 | $883,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 889,082 | $1,503,000 | 0.59% |
MASTERS CAPITAL MANAGEMENT LLC | 4,000,000 | $6,800,000 | 0.15% |
Tibra Equities Europe Ltd | 335,565 | $570,000 | 0.10% |
BRANDYWINE MANAGERS, LLC | 94,583 | $161,000 | 0.09% |
SABBY MANAGEMENT, LLC | 513,430 | $872,000 | 0.05% |
ACUTA CAPITAL PARTNERS, LLC | 180,000 | $307,000 | 0.05% |